机器人全胃切除术中保留脾脏的脾门淋巴结清扫:技术与结局
该回顾性研究纳入2005至2015年93例接受机器人全胃切除+D2淋巴结清扫的胃癌患者,排除1例脾切除后分析92例。91例成功完成机器人保留脾脏脾门淋巴结清扫,平均手术时间287.2分钟,术后并发症率16.3%,5年总生存率86.3%。结论认为该技术可行且安全。
要点
- 机器人保留脾脏脾门淋巴结清扫在92例中成功91例,术中脾动脉损伤1例需同期脾切除
- 平均脾门淋巴结获取数1.9枚,总淋巴结50.8枚,术后并发症率16.3%
- 无胰瘘、全脾梗死或脾动脉延迟性动脉瘤发生,5年总生存率86.3%
核心结论
- 机器人应用于保留脾脏的脾门淋巴结清扫是可行且安全的方法。
研究设计与样本
- 回顾性分析2005至2015年93例接受机器人全胃切除+D2淋巴结清扫的胃癌患者,排除1例明显淋巴结转移行脾切除者,最终分析92例。
主要发现
- 92例中91例成功完成机器人保留脾脏脾门淋巴结清扫,1例因术中脾动脉损伤需同期脾切除。
- 总体平均手术时间和控制台时间分别为287.2±66.0分钟和180.2±47.2分钟,平均估计失血量141.1±227.0毫升。
- 死亡率为1.1%(1/92),总体术后并发症率为16.3%(15/92)。
- 无胰瘘、全脾梗死或脾动脉延迟性动脉瘤病例。
- 总体和脾门平均获取淋巴结数分别为50.8±18.1枚和1.9±2.6枚,5年总生存率为86.3%,5年无复发生存率为87.4%。
临床怎么用
- 对于需行全胃切除+D2淋巴结清扫的胃癌患者,可考虑采用机器人保留脾脏的脾门淋巴结清扫,但需注意术中脾动脉损伤风险。
局限性
- 本研究为回顾性分析,样本量有限,且未设置对照组,结论需进一步前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic system may have potential advantages to facilitate the technically challenging splenic hilar lymphadenectomy during gastrectomy for gastric cancer. However, robotic spleen-preserving splenic hilar lymphadenectomy is performed infrequently not only because of the limited availability of the robot but also because of its technical difficulty. In this study, we describe our technique of performing robotic spleen-preserving splenic hilar lymphadenectomy in detail to facilitate wider application and present operative outcomes and the follow-up results of the procedure. METHODS: From 2005 to 2015, 93 patients underwent robotic total gastrectomy with D2 lymphadenectomy. One patient with obvious lymph node (LN) metastasis received splenectomy and was excluded from the analysis. Intraoperative complications, operation and console time, estimated blood loss, postoperative morbidity and mortality, the number of harvested LNs in total and at the splenic hilum, and 5-year overall survival were analyzed, retrospectively. RESULTS: Among the 92 patients, robotic spleen-preserving splenic hilar lymphadenectomy was successfully performed in 91 patients except one who experienced intraoperative splenic artery injury which demanded splenectomy to be performed simultaneously. The overall mean operation time and console time were 287.2 ± 66.0 and 180.2 ± 47.2 min, respectively. Mean estimated blood loss was 141.1 ± 227.0 ml. The mortality was 1.1% (1/92). The overall postoperative morbidity rate was 16.3% (15/92). There was no case of pancreatic fistula, whole splenic infarction, or the delayed aneurysm of splenic artery. The mean numbers of harvested LNs in total and at the splenic hilum were 50.8 ± 18.1 and 1.9 ± 2.6. The 5-year overall survival was 86.3% and 5-year recurrence-free survival was 87.4%. CONCLUSION: This study suggests that robotic application for spleen-preserving splenic hilar lymphadenectomy could be a feasible and safe method.
引用
- Yang K, Cho M, Roh CK, et al. Robotic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. Surg Endosc. 2019. PMID: 30945060. doi:10.1007/s00464-019-06772-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。